TWYNSTA Drug Patent Profile
✉ Email this page to a colleague
When do Twynsta patents expire, and what generic alternatives are available?
Twynsta is a drug marketed by Boehringer Ingelheim and is included in one NDA.
The generic ingredient in TWYNSTA is amlodipine besylate; telmisartan. There are fifty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amlodipine besylate; telmisartan profile page.
Summary for TWYNSTA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Clinical Trials: | 7 |
Patent Applications: | 2 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TWYNSTA |
What excipients (inactive ingredients) are in TWYNSTA? | TWYNSTA excipients list |
DailyMed Link: | TWYNSTA at DailyMed |
Recent Clinical Trials for TWYNSTA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hanlim Pharm. Co., Ltd. | Phase 1 |
Addpharma Inc. | Phase 3 |
Research Institute for Complex Problems of Cardiovascular Diseases, Russia | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for TWYNSTA
US Patents and Regulatory Information for TWYNSTA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-001 | Oct 16, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-004 | Oct 16, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-003 | Oct 16, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TWYNSTA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-001 | Oct 16, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-003 | Oct 16, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-004 | Oct 16, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TWYNSTA
See the table below for patents covering TWYNSTA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 4212250 | ⤷ Try a Trial | |
China | 1050122 | ⤷ Try a Trial | |
Japan | H05279341 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TWYNSTA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0502314 | C00502314/03 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: TELMISARTAN + AMLODIPIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 61270 08.11.2010 |
0503785 | C300486 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: COMBINATIE VAN OLMESARTANMEDOXOMIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, AMLODIPINEBESYLAAT AND HYDROCHLOORTHIAZIDE; NATL REGISTRATION NO/DATE: RVG 106667, RVG 106671-74, RVG 106682-86 20101221; FIRST REGISTRATION: DE 79810.00.00-79814.00.00 20101216 |
1507558 | 2012/018 | Ireland | ⤷ Try a Trial | PRODUCT NAME: ALISKIREN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AMLODIPINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND HYDROCHLOROTHIAZIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; NAT REGISTRATION NO/DATE: EU/1/11/730/001-060 20111122; FIRST REGISTRATION NO/DATE: SWITZERLAND 6167801-6167805 20110705 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |